DEF 14A: iSpecimen Inc. Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing

iSpecimen Inc. is asking stockholders to approve a reverse stock split at its upcoming annual meeting to maintain compliance with Nasdaq's minimum bid price requirement.

Summary

• iSpecimen Inc. is holding its 2024 annual meeting of stockholders virtually on July 19, 2024, at 10:00 a.m. Eastern Time.
• Stockholders of record as of June 3, 2024, are entitled to vote on several proposals.
• The proposals include the election of two Class III directors, approval of a reverse stock split, and ratification of the appointment of Wolf & Company, P.C. as the independent registered public accounting firm for the year ending December 31, 2024.
• The proposed reverse stock split would range from one-for-ten (1:10) to one-for-twenty (1:20), with the exact ratio determined by the Board of Directors.
• The company is seeking the reverse stock split to increase its stock price above the $1.00 minimum bid price required for continued listing on the Nasdaq Capital Market.
• If approved, the reverse stock split will decrease the number of outstanding shares but will not have a dilutive effect on stockholders, except for minor adjustments due to fractional shares.
• The Board of Directors may abandon the reverse stock split at any time.
• The company received a notice from Nasdaq on October 9, 2023, indicating non-compliance with the minimum bid price requirement.
• As of June 3, 2024, there were 13,075,122 shares of common stock issued and outstanding.
• The closing trading price of iSpecimen's common stock on June 7, 2024, was $0.3989.

Sentiment

Score: 6

Explanation: The document is primarily procedural, outlining the proposals for the annual meeting. The sentiment is neutral, with a slight positive leaning due to the company's efforts to maintain its Nasdaq listing.

Positives

• The reverse stock split is intended to increase the per-share trading price of the common stock, potentially making it more attractive to investors.
• Maintaining the Nasdaq listing is expected to improve the liquidity and marketability of the common stock.
• The Board of Directors has the flexibility to abandon the reverse stock split if it is not in the best interests of the company.
• The company has engaged Kingsdale Advisors to assist in soliciting proxies, which may increase stockholder participation in the vote.

Negatives

• There is no guarantee that the reverse stock split will increase the market price of the common stock proportionately or result in a permanent increase.
• If the per-share market price does not increase proportionately, the company's market capitalization could be reduced.
• The reverse stock split could increase the number of stockholders holding less than a round lot (100 shares), potentially increasing transaction costs for those stockholders.
• The reduced number of outstanding shares after the reverse stock split could adversely affect liquidity.

Risks

• Failure to regain compliance with Nasdaq's minimum bid price requirement could result in delisting of the common stock.
• The reverse stock split may not achieve the desired increase in stock price.
• Increased ability to issue authorized and unissued shares without further stockholder action could be dilutive to existing stockholders.
• The company's business and financial performance, general market conditions, and prospects for future success could impact the stock price.

Future Outlook

The company intends to effect a reverse stock split if necessary to regain compliance with the Nasdaq minimum bid price requirement. The Board of Directors has the discretion to determine the exact ratio and timing of the reverse stock split or to abandon it altogether.

Management Comments

• On behalf of the Board of Directors and management, it is my pleasure to express our appreciation for your continued support.
• Your vote is important to us. Please act as soon as possible to vote your shares.

Industry Context

Many companies facing similar circumstances, such as falling below the minimum bid price requirement, consider reverse stock splits to regain compliance and maintain their listing on major exchanges. This action is often viewed as a way to improve investor perception and attract institutional investors.

Comparison to Industry Standards

• Reverse stock splits are a common strategy for companies to regain compliance with minimum listing requirements on exchanges like Nasdaq and NYSE.
• Comparable companies in the biotechnology and pharmaceutical sectors, such as those listed on the XBI ETF, have also utilized reverse stock splits to maintain listing compliance.
• For example, companies like Ocugen Inc. and BioCryst Pharmaceuticals have previously implemented reverse stock splits to address similar listing issues.
• The success of a reverse stock split in increasing stock price and maintaining compliance varies depending on the company's underlying financial health and market conditions.

Stakeholder Impact

• Shareholders will be impacted by the reverse stock split, potentially affecting the value and liquidity of their shares.
• Employees may be affected by the company's ability to maintain its Nasdaq listing, which could impact morale and stock options.
• Customers and suppliers may be indirectly affected by the company's financial stability and market perception.

Next Steps

• Stockholders need to vote on the proposals outlined in the proxy statement.
• The Board of Directors will determine whether to implement the reverse stock split based on market conditions and other factors.
• The company will continue to monitor its stock price and compliance with Nasdaq listing requirements.

Key Dates

Keywords

reverse stock split, proxy statement, annual meeting, Nasdaq, minimum bid price, directors, auditor, iSpecimen